| 1 |
34526771 | Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies. | 2021 |
1 |
| 2 |
31916186 | Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease. | 2020 Feb |
1 |
| 3 |
32078365 | VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly. | 2020 Mar |
1 |
| 4 |
32277995 | What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery? | 2020 May - Jun |
2 |
| 5 |
30637725 | Dietary natural products as emerging lipoprotein(a)-lowering agents. | 2019 Aug |
1 |
| 6 |
31130489 | Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy. | 2019 Jul - Aug |
4 |
| 7 |
31350625 | Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice. | 2019 Jul 27 |
1 |
| 8 |
31555339 | Therapeutic management of hyperlipoproteinemia (a). | 2019 |
1 |
| 9 |
31655942 | Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives. | 2019 Dec |
2 |
| 10 |
32821700 | Effect of Niacin on Carotid Atherosclerosis in Patients at Low-Density Lipoprotein-Cholesterol Goal but High Lipoprotein (a) Level: a 2-Year Follow-Up Study. | 2019 May |
1 |
| 11 |
30317988 | Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia? | 2018 |
1 |
| 12 |
28078998 | Lipoprotein(a) Management: Pharmacological and Apheretic Treatment. | 2017 |
1 |
| 13 |
28128058 | Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)? | 2017 |
1 |
| 14 |
28185213 | Hyperlipoproteinaemia(a) - apheresis and emerging therapies. | 2017 Mar |
1 |
| 15 |
28628560 | Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy. | 2017 Aug |
6 |
| 16 |
29245288 | Elevated serum lipoprotein(a) as a risk factor for combined intracranial and extracranial artery stenosis in a child with arterial ischemic stroke: A case report. | 2017 Dec |
3 |
| 17 |
27206947 | Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). | 2016 May-Jun |
2 |
| 18 |
27514608 | Lp(a) and cardiovascular risk: Investigating the hidden side of the moon. | 2016 Nov |
1 |
| 19 |
27733255 | Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials. | 2016 Nov |
4 |
| 20 |
27749370 | Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism. | 2016 Dec |
2 |
| 21 |
28032426 | Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. | 2016 Dec |
1 |
| 22 |
25936305 | Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype. | 2015 May |
5 |
| 23 |
25936330 | Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run. | 2015 May |
4 |
| 24 |
26160958 | Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients. | 2015 Sep |
2 |
| 25 |
26515419 | Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus. | 2015 Dec |
3 |
| 26 |
23712600 | Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction. | 2014 May |
1 |
| 27 |
24333007 | Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype. | 2014 Mar |
4 |
| 28 |
25110227 | Dramatic lowering of very high Lp(a) in response to niacin. | 2014 Jul-Aug |
1 |
| 29 |
25318824 | Latest developments in the treatment of lipoprotein (a). | 2014 Dec |
1 |
| 30 |
23357133 | Hyperlipoproteinemia(a): clinical significance and treatment options. | 2013 Jan |
2 |
| 31 |
22264576 | Lipoprotein (a): perspectives from a lipid-referral program. | 2012 Jan-Feb |
2 |
| 32 |
22930813 | Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice. | 2012 Nov |
2 |
| 33 |
21649590 | [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]. | 2011 |
2 |
| 34 |
22027461 | [Lipoprotein(a) as a cardiovascular risk factor]. | 2011 |
1 |
| 35 |
20479580 | Lipoprotein(a): from molecules to therapeutics. | 2010 May-Jun |
1 |
| 36 |
20842562 | Do We Know When and How to Lower Lipoprotein(a)? | 2010 Aug |
1 |
| 37 |
20965889 | Lipoprotein(a) as a cardiovascular risk factor: current status. | 2010 Dec |
1 |
| 38 |
21490914 | The Effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein (a). | 2010 |
1 |
| 39 |
18375241 | Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations. | 2008 Apr 17 |
1 |
| 40 |
19019811 | Practical management of dyslipidemia with elevated lipoprotein(a). | 2008 Nov-Dec |
1 |
| 41 |
15554597 | Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice. | 2004 Jul-Aug |
1 |
| 42 |
11912562 | Acute effects of insulin-like growth factor-1 and recombinant growth hormone on liporotein(a) levels in baboons. | 2002 Apr |
1 |
| 43 |
12027776 | Management of hypercholesterolaemia in postmenopausal women. | 2002 |
1 |
| 44 |
12200755 | Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes. | 2002 Sep |
6 |
| 45 |
10929930 | Current, new and future treatments in dyslipidaemia and atherosclerosis. | 2000 Jul |
1 |
| 46 |
11213533 | L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a). | 2000 Oct |
1 |
| 47 |
28402615 | Triglyceride Lowering Drugs | 2000 |
1 |
| 48 |
10441992 | [Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol]. | 1999 Jun |
2 |
| 49 |
8813450 | Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease. | 1996 Feb |
1 |
| 50 |
8187239 | Lipoprotein(a) and coronary heart disease. | 1994 Jan |
2 |